Skip to main content
Caplight Logo









PLAIO

PLAIO

Private
ReykjavíkEnterprise Softwarehttps://plaio.com

Last Round

Series A

Aug 14, 2024

Total Funding Raised

$7.42M

Company Overview

PLAIO operates in Enterprise Software and is based in Reykjavík. Its latest recorded funding round was a Series A round in August 2024.

PLAIO is a healthtech company that offers an AI-powered SaaS platform designed to digitize and optimize demand, manufacturing, and purchase planning for the pharmaceutical industry.

Sector

Enterprise Software

Verticals

Pharma Supply Chain, Supply Chain, Workflow Automation, Smart Manufacturing, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

PLAIO Comparables

Compare PLAIO with similar companies based on industry and business-model similarity.

PLAIO comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ABC-Plan, Inc.
86%
Körber AG
75%
Leucine
72%
Book a demo to see all comparables

For institutional investors. Book with your work email.

PLAIO Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 14, 2024
GrantDec 13, 2023
Early FundingDec 15, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Johann Gudbjargarson

Founder & CEO

Founding Team

For institutional investors. Book with your work email.

PLAIO Investors

Notable investors and investment history

PLAIO investors
InvestorRounds
Frumtak VenturesSeries A, Early Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 30, 2025

    Added Navamedic AB, a life sciences company, as a customer.

Book a demo to see all signals

For institutional investors. Book with your work email.

PLAIO Filings

Explore SEC and related filing metadata, where available.

PLAIO filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about PLAIO's valuation, stock price, and market status.

Is PLAIO a public or private company?

PLAIO is a private company.

What is the current stock price of PLAIO?

PLAIO is a private company, so its shares have no public market price. Caplight tracks PLAIO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PLAIO worth (valuation)?

Valuation information for PLAIO is not publicly available.

Can I buy PLAIO stock?

PLAIO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PLAIO's last funding round?

PLAIO's most recent funding round was Series A on August 14, 2024.

Who are the main investors in PLAIO?

Key investors in PLAIO include Frumtak Ventures.

Will PLAIO IPO soon?

No public IPO plans have been announced for PLAIO.

How can I track PLAIO secondary market activity?

Caplight tracks bids, offers, and trades in PLAIO's shares on secondary markets.

Firmographic Details

HeadquartersReykjavík
Employee Range28
Year Founded2021
Last FundingAug 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?